SLXN — Silexion Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Cameco, BlackSky, Silexion Therapeutics
Silexion Therapeutics soars on preclinical cancer trial data
U.S. STOCKS ON THE MOVE-Freshworks, Flowco, Target
Silexion Therapeutics falls after $5 mln public offering
Brief: Silexion Therapeutics Announces Pricing Of $5.0 Million Public Offering
Brief: Silexion Therapeutics Amends Share Purchase Agreement With White Lion Capital
Brief: Silexion Therapeutics Announces Additional Promising Preclinical Data For SIL-204, Demonstrating Impressive Synergy With First-Line Pancreatic Cancer Chemotherapies
Brief: Silexion Therapeutics Files For Offering Of Up To 2.6 Million Ordinary Shares Together With Ordinary Warrants
Brief: Silexion Therapeutics Announces 1-For-9 Reverse Share Split
Brief: Silexion Therapeutics Corp - To Issue 5,940,000 Ordinary Shares
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio
Silexion Therapeutics rises on updated data from pancreatic cancer treatment
Brief: Silexion Therapeutics Announces Significant New Data From Phase 2 Trial Of Loder In Non-Resectable Pancreatic Cancer
Brief: Silexion Therapeutics Announces Significant New Data From Phase 2 Trial Of Loder In Non-Resectable Pancreatic Cancer
Brief: Silexion Therapeutics, Moringa Acquisition Corp Announce Close Of Business Combination
Brief: Oncology firm Silexion To Go Public In $62.5 Mln SPAC Deal
Brief: Moringa Acquisition Corp Receives Notice From Nasdaq That Co Was Not In Compliance With Listing Rule
Brief: Moringa Acquisition Receives Notice Of Delisting From Nasdaq
Brief: Moringa Acquisition Corp Announces Adjournment Of Extraordinary General Meeting Of Shareholders To February 9, 2023